WAVE SNP1 & SNP2 – Wave Life Sciences – Enrollment to begin August 2017
Study Sponsor: Wave Life Sciences
Not a Clinical Trial: It is an Observational Study to Determine the Presence of SNP1 or SNP2
Clinical Sites in NC: Wake Forest
Website: http:// www.wavelifesciences.com
Description: The purpose of the study is to find out the prevalence of the SNP1 and/or SNP2 in HD patients. The study consists of one visit for a brief exam and blood specimen collection. The results will be used as a potential pre-screening tool for the PRECISION-HD study. It is expected that about 20-30% of patients will not have SNP1 or SNP2 and will therefore be ineligible for the PRECISION-HD study.